Literature DB >> 13500319

The use of prednisolone in the treatment of disseminated breast carcinoma.

S KOFMAN, D NAGAMANI, R E BUENGER, S G TAYLOR.   

Abstract

Entities:  

Keywords:  BREAST NEOPLASMS/therapy; PREDNISOLONE/therapeutic use

Mesh：

Substances：

Year:  1958        PMID： 13500319     DOI： 10.1002/1097-0142(195801/02)11:1<226::aid-cncr2820110135>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  6 in total

1.  [Cortisone and calcium metabolism].

Authors:  H JESSERER; R KOTZAUREK
Journal:  Klin Wochenschr       Date:  1959-03-15

Review 2.  Systemic therapy in breast cancer: efficacy and cost utility.

Authors:  J F Corry; P E Lønning
Journal:  Pharmacoeconomics       Date:  1994-03       Impact factor: 4.981

Review 3.  Current status of the management of patients with endocrine-sensitive tumors. I. Introduction and carcinoma of the breast.

Authors:  L G Crowley
Journal:  Calif Med       Date:  1969-01

Review 4.  Is there a growing role for endocrine therapy in the treatment of breast cancer?

Authors:  P E Lønning
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

Review 5.  Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved.

Authors:  Per Eystein Lønning; Hans Petter Eikesdal
Journal:  Endocr Relat Cancer       Date:  2013-06-24       Impact factor: 5.678

Review 6.  Treatment of breast cancer with aromatase inhibitors--current status and future prospects.

Authors:  P E Lønning; M Dowsett; T J Powles
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.